Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis (SEER)

This study has been completed.
Sponsor:
Collaborators:
Seer Pharmaceuticals
CF Therapeutics Development Network Coordinating Center
Cystic Fibrosis Foundation Therapeutics
Information provided by:
Ramsey, Bonnie, MD
ClinicalTrials.gov Identifier:
NCT00219882
First received: September 16, 2005
Last updated: December 18, 2007
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2006
  Estimated Primary Completion Date: No date given